Blog

DNA Diagnostics Center® Announces Acquisition of ContraVac, Inc.

May 3, 2018 | Press Releases

 

DNA Diagnostics Center (DDC) Acquires ContraVac, Inc.

 

FAIRFIELD, OhioMay 1, 2018 /PRNewswire/ — DNA Diagnostics Center® (DDC® or the Company), one of the world’s largest private DNA testing companies, announces the acquisition of ContraVacInc., a global leader in male reproductive health.

ContraVac, Inc., based in Charlottesville, VA, markets SpermCheck® Fertility, SpermCheck® Vasectomy and FertileCheck® Fertility Gel.  The SpermCheck® brand of products, developed by ContraVac, is the first FDA-approved immunoassay home-diagnostic test to measure sperm count. Introduced in 2011, SpermCheck® Fertility tests if a man has a fertile or sub-fertile sperm count, and is currently sold nationwide in Walgreens, CVS, Rite Aid, Amazon, and internationally in major retailers. SpermCheck® Vasectomy is the only test designed specifically for men to test the success of their vasectomy at home, eliminating the inconvenience and embarrassment of a laboratory sperm test. The acquisition includes all assets of ContraVac, Inc., which will relocate to DDC’s corporate headquarters in Fairfield, Ohio.
Connie Hallquist, President and Chief Executive Officer of DNA Diagnostics Center®, states: “We are excited about the acquisition of ContraVac, Inc. They have built a strong brand that consumers trust as the global leader in home male fertility testing.”
Ed Leary, Chief Executive Officer of ContraVac, Inc. commented “We are pleased to have the SpermCheck® products in the DDC® product portfolio. DDC’s worldwide sales, marketing and distribution networks will enable us to create global awareness of the frequency of male factor infertility, accounting for up to 50% of couple infertility, and increase the availability of SpermCheck® Fertility for couples who have been trying to conceive without success.” Mr. Leary will join DDC® via the acquisition.
About DNA Diagnostics Center®:
DNA Diagnostics Center ® (DDC®), founded over twenty years ago, is one of the world’s largest private DNA testing companies with offices in Fairfield, Ohio (United States) and London, England (United Kingdom). DDC® offers DNA testing for paternity and family relationships, forensics, genetic traits of animals, and ancestry.
DDC® is accredited by the American Association of Blood Banks (AABB), The Ministry of Justice, The College of American Pathologists (CAP), and The Clinical Laboratory Improvement Amendment (CLIA). DDC is also accredited by ACLASS to meet the international standards of ISO 17025 and the American Society of Crime Laboratory Directors / Laboratory Accreditation Board-International (ASCLD/LAB).  For more information visit www.dnacenter.com.
About ContraVac, Inc:
ContraVac, Inc., a privately held biotechnology company located in Charlottesville, VA, develops over-the-counter fertility products to meet the needs of millions of men who seek actionable information about their fertility health and wish to test themselves in the privacy of their home. ContraVac’s SpermCheck products were developed in collaboration with the Center for Research in Contraceptive and Reproductive Health at the University of Virginia and Princeton BioMeditech Corporation.  For more information visit: www.SpermCheck.com.
Contact: [email protected][/vc_column_text][/vc_column][/vc_row]

1 Comment

  1. nick watson

    Thanx for telling about DNA Diagnostics Center

    Reply

Submit a Comment

Your email address will not be published. Required fields are marked *

DNA Diagnostics Center (DDC) Announces the Launch of Peekaboo Click

DNA Diagnostics Center (DDC) Announces the Launch of Peekaboo Click

FAIRFIELD, OH - DNA Diagnostics Center (DDC), a global leader in genetic relationship and consumer testing, and part of the Eurofins network of companies, today announces the launch of PeekabooTM Click, the latest addition to its Peekaboo Early Gender DNA Test product...

DNA Diagnostics Center Agrees to Join Eurofins via Acquisition

DNA Diagnostics Center Agrees to Join Eurofins via Acquisition

Integration to Expand Global Reach and New Product Innovations Fairfield, OH – (June 25, 2021) – DNA Diagnostics Center (“DDC”) (The Company), announced today the definitive agreement to be acquired by Eurofins, a publicly-traded global laboratory testing business....

Reach Us

Have questions or need assistance? Contact our team.

DNA Technology Park
1 DDC Way
Fairfield, OH 45014

Leave A Message